References
- Aguero-Rosenfeld M.E., Wang G., Swartz I., Wormer G.P.: Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev.18, 484–509 (2005)
- Ates L., Hansen-Hübner C., Norris D.E. Richter D., Kraiczy P., Hunfeld K.-P.: Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borreliaburgdorferi. Ticks Tick Borne Dis.1, 30–34 (2010)
- BrouquiP., Badiaga S., Raoult D.: Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Anti- microb. Agents Chemother. 40, 1552–1554 (1996)
- Chmielewski T., Tylewska-Wierzbanowska S.: Interaction between Borrelia burgdorferi and mouse fibroblasts. Pol. J. Microbiol. 59, 157–160 (2010)
- Comstock L.E., Thomas D.D.: Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect. Immun.57, 1626– 1628 (1989)
- Feng J., Wang T., Shi W., Zhang S., Sullivan D., Auwaerter P. G., Zhang Y.: Identification of novel activity against Borrelia burgdorferipersisters using an FDA approved drug library. Emerg. Microbes Infect. 3, e49 (2014)
- Feng J., Auwaerter P.G., Zhang Y.: Drug combination against Borrelia burgdorferipersisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS ONE, 10, e0117207 (2015)
- Feng J., Zhang S., Shi W., Zhang Y.: Ceftriaxone pulse dosing fails to eradicate bio-like microcolonyB. burgdorferi persisters which are sterilized by daptomycin/doxycycline/cefuroxime without pulse dosing. Front. Microbiol.7, 1744 (2016)
- Hunfeld K.-P., Kraiczy P., Wichelhause T.A., Schäfer V., Brade V.: Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglicosides against Borrelia burgdorferi isolates. Intern. J. Med. Microbiol. 15, 11–17 (2000)
- Hunfeld K.-P., Brade V.: Antimicrobial susceptibility of Borrelia burgdorferi sensulato: what we know, what we don’t known, and what we need to know. Wien. Klin. Wochenschr.22, 659–668 (2006)
- Hunfeld K.-P., Ruzic-Subljic E., Norris D. E., Kraiczy P., Strle F.: In vitro susceptibility testing of Borrelia burgdorferisensulato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob. Agents Chemother. 49, 1294–1301 (2005)
- Hunfeld K.-P., Ruzic-Subljic E., Norris D. E., Kraiczy P., Strle F.: Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance. Intern. J. Med. Microbiol. 296 Suppl. 40, 233–241 (2006)
- Kraiczy P., Weigand J., Wichelhaus T. A., Heising P., Backes H., Schafer V., Acker G., Brade V., Hunfeld K.-P.: In vitro activities of fluorochinolones against the spirochete Borrelia burgdorferi. Antimcrob. Agents Chemiother. 45, 2486–2494 (2001)
- Morgenstern K., Bajler G., Norris D. E., Kraiczy P., Hanssen-Hübner C., Hunfeld K.-P.: In vitro susceptibility of Borreliaspielmanii to microbial agents commonly used for treatment of Lyme disease. Antimicrob. Agents Chemother. 53, 1281–1284 (2009)
- Obonyo M., Munderloch U. G., Fingerle V., Wilske B., Kurtti T.J.: Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature. J. Clin. Microbiol.37, 2137–2141 (1999)
- Tylewska-Wierzbanowska S., Chmielewski T.: The isolation of Borrelia burgdorferi spirochetes from clinical material in cel line cultures. Zbl. Bakt.286, 363–370 (1997)
- Veinovic G., Cerar T., Strle F., Lotric-Furlan S., Maraspin V., Cimperman J., Ruzic-Sabljic E.: In vitro susceptibility of European human Borrelia burgdorferi sensustricto strains to antimicrobial agents. Int. J. Antimicrob. Agents, 41, 288–291 (2013)